Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma

NCT03003520

Conditions
Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +11 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 20 locations
View Trial Details
Completed

Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01027000

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando, Florida, United States
View all 25 locations
View Trial Details
Completed

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

NCT03841110

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +93 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
  • Hackensack University Medical Center/John Theurer Cancer Center Hackensack, New Jersey, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.

NCT00071084

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Stanford University Med Ctr., Dept of Dermatology Stanford, California, United States
  • University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States
  • Münster, Germany
  • Stockholm, Sweden
View Trial Details

Related conditions